These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1215536)

  • 1. Influence of the position of the side chain hydroxy group on the gastric antisecretory and antiulcer actions of E1 prostaglandin analogs.
    Dajani EZ; Driskill DR; Bianchi RG; Collins PW; Pappo R
    Prostaglandins; 1975 Nov; 10(5):733-45. PubMed ID: 1215536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative gastric antisecretory and antiulcer effects of prostaglandin E1 and its methyl ester in animals.
    Dajani EZ; Driskill DR; Bianchi RG; Collins PW
    Prostaglandins; 1975 Aug; 10(2):205-15. PubMed ID: 1178902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SC-29333: a potent inhibitor of canin gastric secretion.
    Dajani EZ; Driskill DR; Bianchi RG; Collins PW; Pappo R
    Am J Dig Dis; 1976 Dec; 21(12):1049-57. PubMed ID: 797257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and gastric antisecretory properties of 15-deoxy-16-hydroxyprostaglandin E analogues.
    Collins PW; Dajani EZ; Driskill DR; Bruhn MS; Jung CJ; Pappo R
    J Med Chem; 1977 Sep; 20(9):1152-9. PubMed ID: 926115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric antisecretory effects of E prostaglandins in Rhesus monkeys.
    Dajani EZ; Callison DA; Bianchi RG; Driskill DR
    Am J Dig Dis; 1976 Dec; 21(12):1020-8. PubMed ID: 827937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric antisecretory actions of (15S)-15-methyl prostaglandin E2 methyl ester and natural prostaglandin E2 in rhesus monkeys.
    Dajani EZ; Callison DA
    Prostaglandins; 1976 May; 11(5):799-808. PubMed ID: 819967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric antisecretory and antiulcer properties of PGE2, 15-methyl PGE2, and 16, 16-dimethyl PGE2. Intravenous, oral and intrajejunal administration.
    Robert A; Schultz JR; Nezamis JE; Lancaster C
    Gastroenterology; 1976 Mar; 70(3):359-70. PubMed ID: 174967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the route of administration of prostaglandin E1 on rat gastric secretion.
    Hong E; Lopez C
    Prostaglandins; 1977 Apr; 13(4):691-6. PubMed ID: 857271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of omega-homologues of prostaglandin E1.
    Dajani EZ; Rozek LF; Sanner JH; Miyano M
    J Med Chem; 1976 Aug; 19(8):1007-10. PubMed ID: 966245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 7-oxa-13-prostynoic acid (7-OPyA) and prostaglandin E1 methyl ester on canine gastric secretion.
    Dajani EZ; Driskill DR
    Prostaglandins; 1977 Oct; 14(4):659-65. PubMed ID: 563608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric antisecretory and antiulcer properties of enprostil, (+/-)-11 alpha, 15 alpha-dihydroxy-16-phenoxy-17,18,19,20-tetranor-9-oxoprosta- 4,5,13(t)-trienoic acid methyl ester.
    Roszkowski AP; Garay GL; Baker S; Schuler M; Carter H
    J Pharmacol Exp Ther; 1986 Nov; 239(2):382-9. PubMed ID: 3095537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric antisecretory effect of 15(R)-15-menthyl PGE2, methyl ester and of 15(S)-15-methyl ester.
    Robert A; Yankee EW
    Proc Soc Exp Biol Med; 1975 Apr; 148(4):1155-8. PubMed ID: 236577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the prostaglandin precursor, arachidonic acid, on histamine stimulated gastric secretion in the conscious dog, and observations on the effect of inhibiting endogenous prostaglandin synthesis.
    Conolly ME; Bieck PR; Payne NA; Adkins B; Oates JA
    Gut; 1977 Jun; 18(6):429-37. PubMed ID: 873324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of prostaglandins E1 and E2 to alter canine gastric mucosal cyclic nucleotides.
    Levine RA; Schwartzel EH; Randall PA; Bachman S
    Prostaglandins; 1979 Jul; 18(1):63-72. PubMed ID: 230540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Slow release delivery of rioprostil by an osmotic pump inhibits the formation of acute aspirin-induced gastric lesions in dogs and accelerates the healing of chronic lesions without incidence of side effects.
    Katz LB; Shriver DA
    Toxicol Appl Pharmacol; 1989 Oct; 101(1):36-46. PubMed ID: 2508266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of prostacyclin and prostaglandin E2 on gastric secretion, gastrin release, and mucosal blood flow in dogs.
    Konturek SJ; Robert A; Hanchar AJ; Nezamis JE
    Dig Dis Sci; 1980 Sep; 25(9):673-9. PubMed ID: 6998689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of rioprostil, a new gastric cytoprotective/antisecretory agent.
    Shriver DA; Rosenthale ME; Kluender HC; Schut RN; McGuire JL; Hong E
    Arzneimittelforschung; 1985; 35(5):839-43. PubMed ID: 3927928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric cytoprotective, antisecretory and antiulcer activities of (E)-4-oxo-4-(3,4,5-trimethoxyphenyl)-2-butenoic acid (RU 38086).
    Barzaghi F; Cesana R; Delevallée F; Fournex R; Nencioni A; Vincent JC; Deraedt R
    Arzneimittelforschung; 1985; 35(9):1412-6. PubMed ID: 4084342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition by prostaglandin E 1 of gastric secretion in the dog.
    Nezamis JE; Robert A; Stowe DF
    J Physiol; 1971 Oct; 218(2):369-83. PubMed ID: 4399409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective gastric antilesion properties of rioprostil, a prostaglandin E1 analog, in rats and dogs.
    Katz LB; Shriver DA; Tobia AJ; Rosenthale ME
    J Pharmacol Exp Ther; 1987 Sep; 242(3):927-33. PubMed ID: 3116199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.